Speaker

Dr. Lynae Brayboy

Chief Medical Officer, CLUE

Dr. Lynae Brayboy, M.D. is CLUE’s first Chief Medical Officer.

Dr. Brayboy is a specialist in reproductive endocrinology, infertility, obstetrics, and gynecology.  She graduated with a Doctor of Medicine (MD) from the Lewis Katz Temple University School of Medicine in Philadelphia in 2007. Between 2007 and 2011, she worked as a Resident at the Abington Hospital Jefferson Health in Pennsylvania.

Her passions and expertise include life sciences, data analysis, pediatrics, oocyte mitochondria, and healthcare information technology (HIT). Not only that, her clinical research has focused specifically on Femtech (a term for technology designed for women’s health, and coined by Clue’s own CEO and co-founder Ida Tin), and providing sexual health education for girls and young women, particularly those of color.

With her demonstrated history of working in the hospital and healthcare industry, Dr. Brayboy will provide a clinical perspective on how Clue can develop to address the unmet requirements of women and people with cycles, and to deliver critical research that will assist healthcare providers. In her new role, she’ll help Clue evolve into the go-to source for women at every reproductive stage: from puberty to menopause.

AllSessions

Day 2
May 27, 2021
5:00 pm

RoundTable: The future of Contraception and Fertility

The field of Fertility and Contraception has long been opaque and difficult to navigate, not mention a field rife with unpleasant and unforeseen Side Effects. Medicine as a whole, however, is entering an era of personalization – this panel will explore in what ways this will revolutionize female contraception (is it impossible to envision a future where female contraception is more specifically tailored to the user?) and fertility....... Pascal Koenig, CEO + Co-Founder of AVA: a bracelet that tracks multiple physiological parameters, including pulse rate, breathing rate, and temperature in order to detect the five most fertile days of a woman’s cycle in real time, while also delivering personalized insight about reproductive health and pregnancy .........Frederik Petursson Madsen, CEO + Co-Founder of Oui: a new approach to contraception that works by topically engineering the cervical mucus to provide effective contraception with minimal side-effects....... Dr. Lynae Brayboy, Chief Medical Officer of Clue: an FDA approved menstrual tracking app........ Eirini Rapti, CEO + Founder of Inne: which uses the hormones found in saliva to determine a woman’s most fertile window thus acting as both a fertility aid or a form of contraception
27 May
Time:  5:00 pm - 6:30 pm
Location:  The field of Fertility and Contraception has long been opaque and difficult to navigate, not mention a field rife with unpleasant and unforeseen Side Effects. Medicine as a whole, however, is entering an era of personalization – this panel will explore in what ways this will revolutionize female contraception (is it impossible to envision a future where female contraception is more specifically tailored to the user?) and fertility....... Pascal Koenig, CEO + Co-Founder of AVA: a bracelet that tracks multiple physiological parameters, including pulse rate, breathing rate, and temperature in order to detect the five most fertile days of a woman’s cycle in real time, while also delivering personalized insight about reproductive health and pregnancy .........Frederik Petursson Madsen, CEO + Co-Founder of Oui: a new approach to contraception that works by topically engineering the cervical mucus to provide effective contraception with minimal side-effects....... Dr. Lynae Brayboy, Chief Medical Officer of Clue: an FDA approved menstrual tracking app........ Eirini Rapti, CEO + Founder of Inne: which uses the hormones found in saliva to determine a woman’s most fertile window thus acting as both a fertility aid or a form of contraception